✦ LIBER ✦

CCL5 as a potential immunotherapeutic target in triple-negative breast cancer

✍ Scribed by Lv, Dandan; Zhang, Yan; Kim, Ha-Jeong; Zhang, Lixing; Ma, Xiaojing

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

524 LRP5: a Potential Therapeutic Target

✍ Maubant, S.; Maire, V.; Tesson, B.; Gentien, D.; Marty-Prouvost, B.; Cruzalegui, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Potential therapeutic target for triple-

✍ Judith A Gilbert 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 96 KB

CD74: a potential novel target for tripl

✍ Tian, Buxian; Zhang, Yuhong; Li, Nan; Liu, Xuewen; Dong, Jianfeng 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 270 KB

Triple-negative breast cancer: investiga

✍ Papa, Anselmo; Caruso, Davide; Tomao, Silverio; Rossi, Luigi; Zaccarelli, Eleono 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 544 KB

The potential to target CCL5/CCR5 in bre

✍ Velasco-Velázquez, Marco; Xolalpa, Wendy; Pestell, Richard G 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 619 KB

Mesothelin, a novel immunotherapy target

✍ Julia Tchou, Liang-Chuan Wang, Ben Selven, Hongtao Zhang, Jose Conejo-Garcia, Ho 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 513 KB